Eric A. Macklin

ORCID: 0000-0003-1618-3502
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Amyotrophic Lateral Sclerosis Research
  • Parkinson's Disease Mechanisms and Treatments
  • Autism Spectrum Disorder Research
  • Child Nutrition and Feeding Issues
  • Hemoglobinopathies and Related Disorders
  • Neurogenetic and Muscular Disorders Research
  • Iron Metabolism and Disorders
  • Family and Disability Support Research
  • Balance, Gait, and Falls Prevention
  • Health Systems, Economic Evaluations, Quality of Life
  • Mindfulness and Compassion Interventions
  • Stroke Rehabilitation and Recovery
  • Folate and B Vitamins Research
  • Neurofibromatosis and Schwannoma Cases
  • Traumatic Brain Injury Research
  • Dysphagia Assessment and Management
  • Genetics and Neurodevelopmental Disorders
  • Neurological disorders and treatments
  • Cerebral Palsy and Movement Disorders
  • Musculoskeletal pain and rehabilitation
  • Pharmacological Effects and Toxicity Studies
  • Statistical Methods in Clinical Trials
  • Resilience and Mental Health
  • Psychosomatic Disorders and Their Treatments
  • Complementary and Alternative Medicine Studies

Massachusetts General Hospital
2016-2025

Harvard University
2016-2025

Clinical Research Institute
2013-2025

Boston University
2010-2024

Lemuel Shattuck Hospital
2010-2024

University of Rochester Medical Center
2023

Toronto Western Hospital
2023

University of Toronto
2023

Public Health Ontario
2023

University of California, San Diego
2023

Dispersal affects community dynamics and vegetation response to global change. Understanding these effects requires descriptions of dispersal at local regional scales statistical models that permit estimation. Classical describe or long-distance dispersal, but not both. The lack methods means have rarely been fitted seed in closed forests. We present a mixture model assumes range disperal patterns, both long distance. bivariate Student's t "2Dt" follows from an assumption the distance...

10.1890/0012-9658(1999)080[1475:sdnafp]2.0.co;2 article EN Ecology 1999-07-01

Recruitment limitation of tree population dynamics is poorly understood, because fecundity and dispersal are difficult to characterize in closed stands. We present an approach that estimates seed production under canopies four limitations on recruitment: density location, fecundity, dispersal, establishment. Consistent obtained for 14 canopy species using 5 yr census data from 100 traps several thousand mapped trees seedlings five southern Appalachian forest stands span gradients elevation...

10.1890/0012-9615(1998)068[0213:sassor]2.0.co;2 article EN Ecological Monographs 1998-05-01

Mutations in SOD1 cause 13% of familial amyotrophic lateral sclerosis. In the Gly93Ala rat model sclerosis, antisense oligonucleotide ISIS 333611 delivered to CSF decreased mRNA and protein concentrations spinal cord tissue prolonged survival. We aimed assess safety, tolerability, pharmacokinetics after intrathecal administration patients with SOD1-related sclerosis.In this randomised, placebo-controlled, phase 1 trial, we by infusion using an external pump over 11·5 h at increasing doses...

10.1016/s1474-4422(13)70061-9 article EN cc-by-nc-nd The Lancet Neurology 2013-03-29

Autism spectrum disorder (ASD), characterized by both impaired communication and social interaction, stereotypic behavior, affects about 1 in 68, predominantly males. The medico-economic burdens of ASD are enormous, no recognized treatment targets the core features ASD. In a placebo-controlled, double-blind, randomized trial, young men (aged 13-27) with moderate to severe received phytochemical sulforaphane (n = 29)--derived from broccoli sprout extracts--or indistinguishable placebo 15)....

10.1073/pnas.1416940111 article EN Proceedings of the National Academy of Sciences 2014-10-13

Aggregated α-synuclein plays an important role in Parkinson's disease pathogenesis. Cinpanemab, a human-derived monoclonal antibody that binds to α-synuclein, is being evaluated as disease-modifying treatment for disease.In 52-week, multicenter, double-blind, phase 2 trial, we randomly assigned, 2:1:2:2 ratio, participants with early receive intravenous infusions of placebo (control) or cinpanemab at dose 250 mg, 1250 3500 mg every 4 weeks, followed by active-treatment dose-blinded extension...

10.1056/nejmoa2203395 article EN New England Journal of Medicine 2022-08-03

IMPORTANCE Convergent biological, epidemiological, and clinical data identified urate elevation as a candidate strategy for slowing disability progression in Parkinson disease (PD).OBJECTIVE To determine the safety, tolerability, urate-elevating capability of precursor inosine early PD to assess its suitability potential design features disease-modification trial. DESIGN, SETTING, AND PARTICIPANTSThe Safety Urate Elevation (SURE-PD) study, randomized, double-blind, placebo-controlled,...

10.1001/jamaneurol.2013.5528 article EN JAMA Neurology 2014-02-01

Abstract An orally administered, fixed‐dose coformulation of sodium phenylbutyrate‐taurursodiol (PB‐TURSO) significantly slowed functional decline in a randomized, placebo‐controlled, phase 2 trial ALS (CENTAUR). Herein we report results long‐term survival analysis participants CENTAUR. In CENTAUR, adults with were randomized 2:1 to PB‐TURSO or placebo. Participants completing the 6‐month (24‐week) eligible receive open‐label extension. all‐cause mortality (35‐month maximum follow‐up...

10.1002/mus.27091 article EN cc-by-nc Muscle & Nerve 2020-10-16
Brent Bluett Daniel M. Togasaki Dragos Mihaila Marian L. Evatt Michael Rezak and 95 more Samay Jain Michael A. Schwarzschild Alberto Ascherio Cindy Casaceli Gary C. Curhan Rebecca C. Fitzgerald Cornelia Kamp Codrin Lungu Eric A. Macklin Kenneth Marek Dariush Mozaffarian David Oakes Alice Rudolph Ira Shoulson Aleksandar Videnović B.L. Scott Lisa Gauger Jason Aldred Melissa Bixby Jill Ciccarello Steven A. Gunzler Claire Henchcliffe Matthew Brodsky Kellie Keith Robert A. Hauser Christopher G. Goetz Mark S. LeDoux Vanessa K. Hinson Rajeev Kumar Alberto J. Espay Joohi Jimenez‐Shahed Christine Hunter Chadwick W. Christine Aaron Daley Maureen A. Leehey Joy Antonelle de Marcaida Joseph H. Friedman Albert Y. Hung Grace Bwala Irene Litvan David K. Simon Tanya Simuni Cynthia Poon Mya C. Schiess Kelvin L. Chou Ariane Park Danish Bhatti Carolyn Peterson Susan R. Criswell Liana S. Rosenthal Jennifer Durphy Holly A. Shill Shyamal H. Mehta Anwar Ahmed Andres Deik John Y. Fang Natividad Stover Lin Zhang Richard B. Dewey Ashley Gerald James T. Boyd Emily Houston Valerie Suski Sherri Mosovsky Leslie Cloud Binit Shah Marie Saint‐Hilaire Raymond James S. Elizabeth Zauber Stephen G. Reich David Shprecher Rajesh Pahwa April Langhammer Kathrin LaFaver Peter A. LeWitt Patricia L. Kaminski John L. Goudreau Doozie Russell David Houghton Ashley LaRoche Karen Thomas Martha McGraw Zoltan Mari Carmen Serrano Karen Blindauer Marcie Rabin Roger Kurlan John C. Morgan Michael J. Soileau Melissa Ainslie Iván Bódis-Wollner Ruth B. Schneider Cheryl Waters Amber Servi Ratel Christopher A. Beck

Urate elevation, despite associations with crystallopathic, cardiovascular, and metabolic disorders, has been pursued as a potential disease-modifying strategy for Parkinson disease (PD) based on convergent biological, epidemiological, clinical data.To determine whether sustained urate-elevating treatment the urate precursor inosine slows early PD progression.Randomized, double-blind, placebo-controlled, phase 3 trial of oral in PD. A total 587 individuals consented, 298 not yet requiring...

10.1001/jama.2021.10207 article EN JAMA 2021-09-14

Abstract Amyotrophic lateral sclerosis (ALS) involves progressive motor neuron loss, leading to paralysis and death typically within 3–5 years of diagnosis. Dysfunctional astrocytes may contribute disease glial cell line-derived neurotrophic factor (GDNF) can be protective. Here we show that human neural progenitor cells transduced with GDNF (CNS10-NPC-GDNF) differentiated protected spinal neurons were safe in animal models. CNS10-NPC-GDNF transplanted unilaterally into the lumbar cord 18...

10.1038/s41591-022-01956-3 article EN cc-by Nature Medicine 2022-09-01

Increasing atmospheric carbon dioxide is responsible for climate changes that are having widespread effects on biological systems. One of the clearest earlier onset spring and lengthening growing season. We designed present study to examine interactive timing dormancy release seeds with low high CO2 biomass, reproduction, phenology in ragweed plants (Ambrosia artemisiifolia L.), which produce highly allergenic pollen. released from at three 15-day intervals grew climate-controlled...

10.1289/ehp.8549 article EN public-domain Environmental Health Perspectives 2006-02-09

Adults with beta thalassemia major frequently have low BMD, fractures, and bone pain. The purpose of this study was to determine the prevalence pain in all syndromes childhood, adolescence, adulthood, associations BMD fractures pain, etiology disease thalassemia. Patients Thalassemia Clinical Research Network, > or =6 yr age, no preexisting medical condition affecting mass requiring steroids, participated. We measured spine femur whole body BMC by DXA assessed vertebral abnormalities...

10.1359/jbmr.080505 article EN Journal of Bone and Mineral Research 2008-05-27

The objective of this study was to characterize the diagnostic timelines and their predictors in people with amyotrophic lateral sclerosis (ALS). Patients were identified through ALS billing codes. Time from presenting symptom first doctor visit, visit suspected diagnosis, confirmed diagnosis (total time) collected. Regression models used analyze delay. Three hundred four patients included analysis. Median total time 11.5 months. Diagnostic longer age > 60 years (p < 0.001), sporadic =...

10.3109/21678421.2014.903974 article EN Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2014-07-01

This study aimed to determine differences in the rates of growth, endocrine- and calcium-related abnormalities various thalassemia syndromes North America treated with current therapies. Medical history, physical examinations blood urine collections were obtained from patients all age 6 years older Thalassemia Clinical Research Network. 361 subjects, 49% male, mean 23.2 (range 6.1-75 years) studied. Approximately 25% children adults, regardless syndrome, had short stature. Overall growth was...

10.1111/j.1365-2141.2009.07793.x article EN British Journal of Haematology 2009-07-13

Abstract Purpose: Resistance to temozolomide chemotherapy is partly mediated by O6-methylguanine-DNA methlytransferase (MGMT). Protracted treatment with potentially overcomes MGMT resistance and improves outcome. We conducted a phase II study of protracted daily in adults low-grade gliomas. Experimental Design: Patients newly diagnosed oligodendroglioma or oligoastrocytoma MIB-1 index &amp;gt;5% recurrent gliomas received (75 mg/m2/day 11-week cycles 7 weeks on/4 off). Treatment continued...

10.1158/1078-0432.ccr-08-0888 article EN Clinical Cancer Research 2008-12-31

An analysis of a prospective cohort individuals with sickle cell anemia (SCA), enrolled from birth through adulthood, was conducted to determine if asthma is risk factor for death in SCA. All-cause mortality determined participants after adjusting known factors The study included 1,963 who were followed 18,495 patient-years. After controlling established factors, SCA and had more than two-fold higher (hazard ratio 2.36, 95% CI 1.21 4.62, p=0.01). To summarize,

10.3324/haematol.11213 article EN cc-by-nc Haematologica 2007-08-01

More effective treatments are needed for negative symptoms of schizophrenia, which typically chronic, disabling, and costly. Negative have previously been associated with reduced blood folate levels, especially among patients low-functioning variants in genes that regulate metabolism, suggesting the potential utility supplementation.To determine whether folic acid plus vitamin B12 supplementation reduces schizophrenia functional folate-related influence treatment response.Parallel-group,...

10.1001/jamapsychiatry.2013.900 article EN JAMA Psychiatry 2013-03-07

Aliment Pharmacol Ther 2011; 34: 1328–1336 Summary Background Many patients with ulcerative colitis (UC) and Crohn’s disease (CD) complain of significant fatigue. To date, no instrument to measure fatigue has been validated in a US inflammatory bowel (IBD) population. Aim determine the reliability validity Functional Assessment Chronic Illness Therapy‐Fatigue (FACIT‐F) scale IBD. Methods A total 209 IBD completed 13 items FACIT‐F, alongside laboratory testing activity assessment. Internal...

10.1111/j.1365-2036.2011.04871.x article EN Alimentary Pharmacology & Therapeutics 2011-10-17
Coming Soon ...